California Board of Pharmacy - Enforcement Committee and E‐Pedigree Public Meetings - June 12, 2012 Agenda
II. Discussion on the Implementation of California’s Electronic Pedigree Requirements for Prescription Medication
a. Discussion about the Presence of Counterfeit Avastin and Altuzan in California Physician Offices and Clinics
b. Dysfunction In California’s Supply of Prescription Medication Discovered During Board of Pharmacy Investigations
c. Board of Pharmacy’s Letters to Federal Representatives and Senators on Elements Needed in any Proposal for Federal Legislation
d. Colloquy from Senators Enzi and Harkin in Support of Retaining Protections in California Law in Future Federal Requirements for Tracking Prescription Medications Through Pharmaceutical Supply Chain
e. Presentations and Questions from the Pharmaceutical Supply Chain on Their Readiness to Meet California’s Staggered E‐Pedigree Implementation Schedule 1. Robert Celeste, Director, Healthcare, GS1 US 2. Other Companies, Associations and Other Entities Wishing to Address the Committee on E‐Pedigree Issues
f. General Discussion
g. Discussion and Possible Action to Develop Regulation Requirements Specifying a Unique Identification Number for Prescription Medication Pursuant to California’s E‐Pedigree Requirements
h. Discussion and Possible Action to Develop “Grandfathering” Provisions for Non‐Pedigreed Dangerous Drugs Pursuant to Section 4163.2 of the Business and Professions Code
i. Discussion concerning Elements for Inference as Provided by California Business and Professions Code Section 4163.3
j. Closing Comments
Return Home: The Designated Representative and Exemptee Blog
CA Designated Representative online CBT training certification by SkillsPlus Intl Inc.
CA HMDR Exemptee online CBT training certification by SkillsPlus Intl Inc.
FL Designated Representative online CBT exam preparation by SkillsPlus Intl Inc.
SkillsPlus Intl Info Blog
